The role of survivin splice variants in pancreatic ductal adenocarcinoma Gemcitabine resistance

被引：1
|
作者：
Kabagwira, Janviere [1 ]
Gonda, Amber [1 ]
Kwong, Mei Li [1 ]
机构：
[1] Loma Linda Univ, Loma Linda, CA 92350 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3021
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
    Natu, Jay
    Nagaraju, Ganji Purnachandra
    CANCER LETTERS, 2023, 573
  • [32] Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation
    Ju, Huai-Qiang
    Li, Hao
    Tian, Tian
    Lu, Yun-Xin
    Bai, Long
    Chen, Le-Zong
    Sheng, Hui
    Mo, Hai-Yu
    Zeng, Jun-Bo
    Deng, Wuguo
    Chiao, Paul J.
    Xu, Rui-Hua
    JOURNAL OF PINEAL RESEARCH, 2016, 60 (01) : 27 - 38
  • [33] CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy
    Liu, Zhi-De
    Shi, Yin-Hao
    Xu, Qiong-Cong
    Zhao, Guang-Yin
    Zhu, Ying-Qin
    Ma, Ming-Jian
    Ye, Jing-Yuan
    Xu, Xiang
    Wang, Jie-Qin
    Zhao, Wei
    Yin, Xiao-Yu
    CANCER LETTERS, 2024, 585
  • [34] Bioinformatics-based screening of key genes associated with gemcitabine resistance in advanced pancreatic ductal adenocarcinoma
    Hu, Kaifeng
    Hasegawa, Kiyoshi
    Zhou, Guozhi
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (12) : 6947 - 6955
  • [35] Correlation Between the Acquisition of Resistance to Gemcitabine Therapy and the Expression of HuR in Pancreatic Ductal Adenocarcinoma: A Case Report
    Oba, Atsushi
    Ban, Daisuke
    Kudo, Atsushi
    Kirimura, Susumu
    Ito, Hiromitsu
    Matsumura, Satoshi
    Mitsunori, Yusuke
    Aihara, Arihiro
    Ochiai, Takanori
    Tanaka, Shinji
    Tanabe, Minoru
    INTERNATIONAL SURGERY, 2018, 103 (1-2) : 116 - 120
  • [36] SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling
    Yu, Hao
    Mei, Xiaoping
    Zhang, Xueming
    Qian, Neng
    Yu, Qingjiang
    Zhou, Hong-Kun
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2024, 19 (02)
  • [37] The role of exosomes in promoting acquired resistance to gemcitabine and nanoparticle albumin-bound (NAB) paclitaxel in pancreatic ductal adenocarcinoma cells.
    Khushman, Moh'd M.
    Patel, Girijesh K.
    Bhardwaj, Arun
    Srivastava, Sanjeev K.
    Khan, Mohammad Aslam
    Singh, Seema
    Brandt, Benjamin
    Taylor, William R.
    Singh, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma
    Zhang, Tianpeng
    Gu, Zongting
    Ni, Ran
    Wang, Xiao
    Jiang, Qitao
    Tao, Ran
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12): : 361
  • [39] Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma
    Tada, Motohisa
    Ijichi, Hideaki
    Miyabayashi, Koji
    Saoka, Yoshinari A.
    Mohri, Dai
    Ikenoue, Tsuneo
    Mikata, Rintarou
    Tawada, Katsunobu
    Ishihara, Takeshi
    Kanai, Fumihiko
    Imazeki, Fumio
    Omata, Masao
    Moses, Harold L.
    Yokosuka, Osamu
    CANCER RESEARCH, 2012, 72
  • [40] Gemcitabine nanoparticles show in vitro efficacy in murine pancreatic ductal adenocarcinoma
    Tucci, Samantha T.
    Kakwere, Hamilton
    Kheirolomoom, Azadeh
    Seo, Jai W.
    Ingham, Elizabeth
    Hwang, Chang-Il
    Ferrara, Katherine
    CANCER RESEARCH, 2017, 77
12345